PCK1 and hepatocellular carcinoma: Moreover, increased phosphorylation of phosphoenolpyruvate carboxykinase 1 (PCK1) correlates with reduced survival rates of patients with HCC, positioning PCK1 phosphorylation as a potential prognostic marker for HCC outcomes [70].